Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-18 Purchase(A) | 2026-10-02 6:49 pm | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 1,000 | $3.92 | $3,920 | 23,881 (Direct) | View |
| 2026-08-18 Purchase | 2026-08-20 06:01 am | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 1,000 | $3.92 | $3,920 | 123,542 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-02 Option Award | 2026-10-05 5:02 pm | N/A 2036-06-24 | Z Squared Inc. | ZSQR | Harris Jeffery Keeslar Chief Technology Officer | 100,000 | $0 | 112,444 (Direct) | View |
| 2026-07-27 Exercise | 2026-10-02 7:50 pm | N/A N/A | Z Squared Inc. | ZSQR | Halabu David Elias Chief Executive Officer | 19,737 | $0 | 1,570,749 (Direct) | View |
| 2026-04-27 Option Award | 2026-10-02 7:50 pm | N/A N/A | Z Squared Inc. | ZSQR | Halabu David Elias Chief Executive Officer | 78,947 | $0 | 1,570,749 (Direct) | View |
| 2026-05-27 Exercise | 2026-10-02 7:34 pm | N/A N/A | Z Squared Inc. | ZSQR | Sohn Adam Craig Director | 1,370 | $0 | 46,600 (Direct) | View |
| 2026-05-27 Exercise | 2026-10-02 7:30 pm | N/A N/A | Z Squared Inc. | ZSQR | Fuerst Bryan Eric Director | 1,370 | $0 | 46,600 (Direct) | View |
| 2026-05-27 Exercise | 2026-10-02 7:29 pm | N/A N/A | Z Squared Inc. | ZSQR | Cooper Kenneth Lyle Director | 1,370 | $0 | 46,600 (Direct) | View |
| 2026-09-24 Exercise | 2026-10-02 7:15 pm | N/A N/A | Z Squared Inc. | ZSQR | Harris Jeffery Keeslar Chief Technology Officer | 12,444 | $0 | 49,778 (Direct) | View |
| 2026-07-27 Exercise | 2026-10-02 7:06 pm | N/A N/A | Z Squared Inc. | ZSQR | Cogley Brian Chief Financial Officer | 4,112 | $0 | 38,947 (Direct) | View |
| 2026-07-27 Exercise(A) | 2026-10-02 6:49 pm | N/A N/A | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 3,169 | $0 | 23,881 (Direct) | View |
| 2026-08-24 Option Award | 2026-08-25 6:56 pm | N/A N/A | Z Squared Inc. | ZSQR | Harris Jeffery Keeslar Chief Technology Officer | 49,778 | $0 | 49,778 (Direct) | View |
| 2026-06-03 Option Award | 2026-08-20 06:01 am | N/A N/A | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 112,674 | $0 | 123,542 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-08 4:01 pm | N/A N/A | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 2,806 | $0 | 12,674 (Direct) | View |
| 2026-04-30 Other | 2026-05-15 09:11 am | N/A N/A | Z Squared Inc. | ZSQR | BSG Series CM LLC 10% Owner | 41,521,276 | $0 | 41,521,276 (Direct) | View |
Ownership | 2026-05-04 8:05 pm | N/A N/A | Z Squared Inc. | COEP | BSG Series CM LLC 10% Owner | 0 | $0 | 41,521,276 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:13 am | N/A N/A | Z Squared Inc. | ZSQR | Sohn Adam Craig Director | 9,868 | $0 | 9,868 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:11 am | N/A 2036-04-27 | Z Squared Inc. | ZSQR | Schadel Christopher Ryan Chief Marketing Officer | 109,868 | $0 | 109,868 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:10 am | N/A 2036-04-27 | Z Squared Inc. | ZSQR | Halabu David Elias Co-Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:08 am | N/A N/A | Z Squared Inc. | ZSQR | Fuerst Bryan Eric Director | 9,868 | $0 | 9,868 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:07 am | N/A N/A | Z Squared Inc. | ZSQR | Cooper Kenneth Lyle Director | 9,868 | $0 | 9,868 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:06 am | N/A 2036-04-27 | Z Squared Inc. | ZSQR | Cogley Brian Chief Financial Officer | 116,447 | $0 | 116,447 (Direct) | View |
| 2026-04-27 Option Award | 2026-04-30 06:05 am | N/A N/A | Z Squared Inc. | ZSQR | Burke Michelle Ellen Co-Chief Executive Officer | 16,447 | $0 | 16,447 (Direct) | View |
Ownership | 2026-04-29 8:01 pm | N/A N/A | Z Squared Inc. | ZSQR | Halabu David Elias Co-Chief Executive Officer | 0 | $0 | 1,412,855 (Indirect) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 10,000 | $10.56 | 22,500 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 12,500 | $0 | 22,500 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 5,700 | $10.56 | 368,741 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 3,250 | $0 | 368,741 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 148,875 | $7.05 | 330,192 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 51,250 | $0 | 330,192 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP Operations | 10,000 | $10.41 | 70,531 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP Operations | 20,000 | $0 | 70,531 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 5,700 | $10.56 | 13,161 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 3,250 | $0 | 13,161 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 1,000 | $10.56 | 64,031 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 12,500 | $0 | 64,031 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-10 9:23 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 5,700 | $0 | 8,950 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:29 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 10,000 | $0 | 22,500 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:29 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP of Operations | 5,000 | $0 | 25,000 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:28 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 1,000 | $0 | 13,500 (Direct) | View |